Equivalency Study of the TEG and CORA Hemostasis Systems

CompletedOBSERVATIONAL
Enrollment

465

Participants

Timeline

Start Date

January 31, 2013

Primary Completion Date

December 31, 2013

Study Completion Date

December 31, 2013

Conditions
Heart DiseaseFocus is on Testing Performance of CORA Hemostasis System.
Trial Locations (4)

15147

Magee-Women's Hospital of UPMC, Pittsburgh

20010

Medstar Health Research Institute - Washington Hospital Center, Washington D.C.

21215

Sinai Center for Thrombosis Research, Sinai Hospital, Baltimore

55905

Mayo Clinic, Rochester

Sponsors
All Listed Sponsors
lead

Coramed Technologies LLC

INDUSTRY

NCT01790386 - Equivalency Study of the TEG and CORA Hemostasis Systems | Biotech Hunter | Biotech Hunter